Drug Profile
MDL 62879
Alternative Names: GE 2270ALatest Information Update: 24 Jun 2002
Price :
$50
*
At a glance
- Originator Aventis
- Class Antiacnes; Antibacterials; Peptide antibiotics; Peptides
- Mechanism of Action Protein synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bacterial infections